Bandwidth (NASDAQ:BAND – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at William ...

William Blair reduced their Q1 2025 earnings per share (EPS) estimates for Sapiens International in a report released on Tuesday, February 18th. William Blair analyst D. Becker now anticipates that ...

Fintel reports that on February 21, 2025, William Blair downgraded their outlook for CACI International (NYSE:CACI) from ...

Fintel reports that on February 21, 2025, William Blair downgraded their outlook for Booz Allen Hamilton Holding (NYSE:BAH) ...

William Blair downgraded Booz Allen (BAH) to Market Perform from Outperform.Discover the Best Stocks and Maximize Your Portfolio: See what ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

William Blair analyst Brian Drab maintained a Buy rating on Novanta (NOVT – Research Report) today. The company’s shares closed today at ...

Pediatrix Medical reported Q4 revenue of $502.36 million, surpassing estimates, with adjusted EPS of $0.51. The company ...

William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named managing directors John Ivey and B.T. Remmert as the ...

Repligen Corp (NASDAQ:RGEN) released its fourth-quarter adjusted EPS of 44 cents on Tuesday, down from 48 cents a year ago ...